Ratings Swiss Re Ltd Deutsche Boerse AG

Equities

SR9

CH0126881561

Market Closed - Deutsche Boerse AG Other stock markets 10:20:52 2019-06-28 am EDT			5-day change	1st Jan Change
89.02 ^EUR	+1.04%		-.--%	-.--%

Apr. 22	Swiss Re to Roll Out AI-Powered Insurance Underwriting Assistant	MT
Apr. 15	Swiss Re Appoints New Chairman	MT

Summary

The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

Its low valuation, with P/E ratio at 9.71 and 8.67 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
With regards to fundamentals, the enterprise value to sales ratio is at 0.7 for the current period. Therefore, the company is undervalued.
The company is one of the best yield companies with high dividend expectations.
Over the past year, analysts have regularly revised upwards their sales forecast for the company.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.

Weaknesses

The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Reinsurance

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
SWISS RE LTD	-.--%	31.59B		-
GENERAL INSURANCE CORPORATION OF INDIA	+14.82%	7.18B		-
BROOKFIELD REINSURANCE LTD.	+1.24%	5.9B	-	-
SCOR SE	+18.52%	5.82B		B
ENSTAR GROUP LIMITED	-0.53%	4.23B	-	B
KOREAN REINSURANCE COMPANY	+13.85%	869M		C-
CENTRAL REINSURANCE CORPORATION	+19.74%	664M	-	-
POZAVAROVALNICA SAVA, D.D.	+7.14%	493M	-	-
MNRB HOLDINGS	+41.80%	284M		B-
HELIOS UNDERWRITING PLC	+9.84%	154M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes